Role of DAT-SPECT in the diagnostic work up of Parkinsonism

被引:155
作者
Scherfler, Christoph
Schwarz, Johannes
Antonini, Angelo
Grosset, Donald
Valldeoriola, Francese
Marek, Kenneth
Oertel, Wolfgang
Tolosa, Eduardo
Lees, Andrew J.
Poewe, Werner
机构
[1] Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria
[2] Neurol Klin & Poliklin, Leipzig, Germany
[3] Ist Clin Perfezionamento, Parkinson Inst, Milan, Italy
[4] So Gen Hosp, Inst Neurol Sci, Dept Neurol, Glasgow G51 4TF, Lanark, Scotland
[5] Univ Barcelona, Inst Invest Biomed August Pi & Suner, Hosp Clin Barcelona, Dept Neurol,Parkinsons Dis & Movement Disorders U, E-08007 Barcelona, Spain
[6] Inst Neurodegenerat Disorders, New Haven, CT USA
[7] Univ Marburg, Neurol Klin, D-35032 Marburg, Germany
[8] Royal Free Hosp, Reta Lila Weston Inst Neurol Studies, London NW3 2QG, England
[9] UCL, Sch Med, London W1N 8AA, England
关键词
dopamine transporter; SPECT; Parkinson's disease; differential diagnosis;
D O I
10.1002/mds.21505
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The diagnosis of idiopathic Parkinson's disease (PD) can be achieved with high degrees of accuracy in cases with full expression of classical clinical features. However, diagnostic uncertainty remains in early disease with subtle or ambiguous signs. Functional imaging has been suggested to increase the diagnostic yield in parkinsonian syndromes with uncertain clinical classification. Loss of striatal dopamine nerve terminal function, a hallmark of neurodegenerative Parkinsonism, is strongly related to decreases of dopamine transporter (DAT) density, which can be measured by single photon emission computed tomography (SPECT). The use of DAT-SPECT facilitates the differential diagnosis in patients with isolated tremor symptoms not fulfilling PD or essential tremor criteria, drug-induced, psychogenic and vascular Parkinsonism as well as dementia when associated with Parkinsonism. This review addresses the value of DAT-SPECT in early differential diagnosis, and its potential as a screening tool for subjects at risk of developing PD as well as issues around the assessment of disease progression. (c) 2007 Movement Disorder Society
引用
收藏
页码:1229 / 1238
页数:10
相关论文
共 113 条
[1]   Comparison of region-of-interest analysis and human observers in the diagnosis of Parkinson's disease using [99mTc]TRODAT-1 and SPECT [J].
Acton, PD ;
Newberg, A ;
Plössl, K ;
Mozley, PD .
PHYSICS IN MEDICINE AND BIOLOGY, 2006, 51 (03) :575-585
[2]   Slowing Parkinson's disease progression - Recent dopamine agonist trials [J].
Ahlskog, JE .
NEUROLOGY, 2003, 60 (03) :381-389
[3]   123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy [J].
Antonini, A ;
Benti, R ;
De Notaris, R ;
Tesei, S ;
Zecchinelli, A ;
Sacilotto, G ;
Meucci, N ;
Canesi, M ;
Mariani, C ;
Pezzoli, G ;
Gerundini, P .
NEUROLOGICAL SCIENCES, 2003, 24 (03) :149-150
[4]   A STUDY OF THE EARLY SIGNS OF DRUG-INDUCED PARKINSONISM [J].
ARBLASTER, LA ;
LAKIE, M ;
MUTCH, WJ ;
SEMPLE, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1993, 56 (03) :301-303
[5]   [123I]β-CIT and SPECT in essential tremor and Parkinson's disease [J].
Asenbaum, S ;
Pirker, W ;
Angelberger, P ;
Bencsits, G ;
Pruckmayer, M ;
Brücke, T .
JOURNAL OF NEURAL TRANSMISSION, 1998, 105 (10-12) :1213-1228
[6]  
Asenbaum S, 1997, J NUCL MED, V38, P1
[7]  
Benamer HTS, 2000, MOVEMENT DISORD, V15, P692, DOI 10.1002/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO
[8]  
2-V
[9]  
Benamer HTS, 2000, MOVEMENT DISORD, V15, P503, DOI 10.1002/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO
[10]  
2-V